OZEMPIC - Scientific miracle drug for weight loss?
Sources and references for the latest Youtube video about the new wonder drug on the market - Ozempic - that promises weight loss without nasty surprises
https://www.youtube.com/watch?v=GoM-64EkchU
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209637Orig1s000MedR.pdf
https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20(WEGOVY%C2%AE)%20Injection&st=c
Wilding, J. P. H. et al. "Once-weekly semaglutide in adults with overweight or obesity." New England Journal of Medicine, 2021.
Frías, J. P. et al. "Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes." New England Journal of Medicine 385, 2021, 503-515.
Wilding, J. P. H. et al. "Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension." Diabetes, Obesity and Metabolism 24, 2022, 1553-1564.
Parks, M.; Rosebraugh, C. "Weighing risks and benefits of liraglutide—the FDA's review of a new antidiabetic therapy." New England Journal of Medicine 362, 2010, 774-777.
Thomas, A., et al. "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity." JAMA 325.14 (2021): 1-11.
Drucker, Daniel J. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." Cell metabolism 27.4 (2018): 740-756.
https://theconversation.com/ozempic-helps-people-lose-weight-but-who-should-be-able-to-use-it-196794
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf